Hardman Johnston Global Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.6M Sell
191,504
-7,360
-4% -$705K 0.79% 32
2025
Q4
$19.1M Sell
198,864
-36,295
-15% -$3.53M 0.91% 32
2025
Q3
$22.4M Buy
235,159
+48,616
+26% +$4.47M 1.1% 30
2025
Q2
$16.3M Sell
186,543
-125
-0.1% -$10.6K 0.72% 37
2025
Q1
$16.8M Sell
186,668
-4,450
-2% -$398K 0.8% 36
2024
Q4
$15.3M Sell
191,118
-6,270
-3% -$543K 0.63% 37
2024
Q3
$17.8M Sell
197,388
-24,210
-11% -$2.04M 0.7% 35
2024
Q2
$17.4M Sell
221,598
-3,485
-2% -$286K 0.67% 35
2024
Q1
$19.6M Sell
225,083
-175
-0.1% -$14.9K 0.68% 39
2023
Q4
$18.6M Sell
225,258
-2,215
-1% -$169K 0.6% 40
2023
Q3
$17.8M Sell
227,473
-4,740
-2% -$397K 0.6% 40
2023
Q2
$20.5M Sell
232,213
-4,669
-2% -$402K 0.66% 41
2023
Q1
$19.1M Sell
236,882
-5,520
-2% -$450K 0.62% 42
2022
Q4
$18.8M Sell
242,402
-3,750
-2% -$304K 0.74% 39
2022
Q3
$19.9M Sell
246,152
-660
-0.3% -$59.3K 0.89% 37
2022
Q2
$22.2M Sell
246,812
-1,080
-0.4% -$109K 0.94% 36
2022
Q1
$27.5M Buy
247,892
+50
+0% +$5.28K 0.88% 36
2021
Q4
$25.6M Sell
247,842
-9,643
-4% -$1.12M 0.69% 39
2021
Q3
$32.3M Sell
257,485
-297
-0.1% -$38.4K 0.87% 28
2021
Q2
$32M Sell
257,782
-6,995
-3% -$878K 0.77% 30
2021
Q1
$31.3M Sell
264,777
-1,100
-0.4% -$129K 0.89% 29
2020
Q4
$31.1M Sell
265,877
-2,430
-0.9% -$268K 0.9% 26
2020
Q3
$27.9M Sell
268,307
-3,130
-1% -$314K 1.04% 25
2020
Q2
$24.9M Sell
271,437
-360
-0.1% -$34.5K 1.1% 22
2020
Q1
$24.5M Sell
271,797
-3,010
-1% -$320K 1.43% 20
2019
Q4
$31.2M Sell
274,807
-5,240
-2% -$575K 1.26% 22
2019
Q3
$30.4M Sell
280,047
-1,200
-0.4% -$125K 1.39% 20
2019
Q2
$27.4M Sell
281,247
-8,400
-3% -$767K 1.21% 22
2019
Q1
$26.4M Sell
289,647
-6,130
-2% -$549K 1.16% 22
2018
Q4
$26.9M Sell
295,777
-2,520
-0.8% -$235K 1.39% 18
2018
Q3
$29.3M Sell
298,297
-2,470
-0.8% -$228K 1.27% 21
2018
Q2
$25.7M Sell
300,767
-17,370
-5% -$1.45M 1.09% 23
2018
Q1
$25.5M Sell
318,137
-6,570
-2% -$542K 1.09% 23
2017
Q4
$26.2M Buy
324,707
+365
+0.1% +$29.2K 1.11% 28
2017
Q3
$25.2M Buy
324,342
+2,110
+0.7% +$175K 1.08% 26
2017
Q2
$28.6M Buy
322,232
+1,020
+0.3% +$86K 1.23% 24
2017
Q1
$25.9M Sell
321,212
-14,726
-4% -$1.15M 1.16% 24
2016
Q4
$23.9M Sell
335,938
-3,239
-1% -$254K 1.17% 26
2016
Q3
$29.3M Sell
339,177
-17,645
-5% -$1.54M 1.33% 19
2016
Q2
$31M Sell
356,822
-19,880
-5% -$1.61M 1.58% 18
2016
Q1
$28.3M Sell
376,702
-3,330
-0.9% -$251K 1.66% 20
2015
Q4
$29.2M Buy
380,032
+790
+0.2% +$59.5K 1.94% 14
2015
Q3
$25.4M Buy
379,242
+5,680
+2% +$418K 1.69% 20
2015
Q2
$27.7M Sell
373,562
-15,030
-4% -$1.15M 1.66% 22
2015
Q1
$30.3M Sell
388,592
-2,480
-0.6% -$188K 1.83% 17
2014
Q4
$28.2M Sell
391,072
-11,015
-3% -$765K 1.53% 20
2014
Q3
$24.9M Sell
402,087
-16,880
-4% -$1.07M 1.38% 25
2014
Q2
$26.7M Sell
418,967
-9,230
-2% -$561K 1.43% 26
2014
Q1
$26.4M Sell
428,197
-3,869
-0.9% -$225K 1.54% 25
2013
Q4
$24.8M Buy
432,066
+2,270
+0.5% +$129K 1.63% 26
2013
Q3
$22.9M Sell
429,796
-6,102
-1% -$328K 1.53% 27
2013
Q2
$22.4M Buy
+435,898
New +$21.5M 1.54% 26

Other funds holding MDT

Hardman Johnston Global Advisors's MDT Position: Q1 2026 in Review

Hardman Johnston Global Advisors reduced its Medtronic (MDT) stake by 3.7% in Q1 2026, selling an estimated $705K and leaving 191,504 shares worth $16.6M. The position accounts for 0.79% of the portfolio, ranked #32.

Hardman Johnston Global Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.3M in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hardman Johnston Global Advisors held 191,504 shares of Medtronic worth $16.6M as of Q1 2026.
  • Hardman Johnston Global Advisors sold 7,360 Medtronic shares in Q1 2026, an estimated $705K.
  • Medtronic made up 0.79% of Hardman Johnston Global Advisors's portfolio in Q1 2026, its #32 holding.
  • Hardman Johnston Global Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Hardman Johnston Global Advisors's Medtronic position peaked at $32.3M in Q3 2021.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hardman Johnston Global Advisors's 13F filing for Q1 2026, filed 13 May 2026.